Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Baxter International Inc (BAX) Common Stock

Sell:$80.84 Buy:$80.85 Change: $0.06 (0.07%)
Market closed |  Prices as at close on 24 September 2021 | Switch to live prices |
Change: $0.06 (0.07%)
Market closed |  Prices as at close on 24 September 2021 | Switch to live prices |
Change: $0.06 (0.07%)
Market closed |  Prices as at close on 24 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.

Contact details

1 Baxter Pkwy
United States
+1 (847) 9482000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$40.52 billion
Shares in issue:
499.91 million
Health Care Equipment
New York Stock Exchange
United States
US dollar

Key personnel

  • Jose Almeida
    Chairman of the Board, President, Chief Executive Officer
  • James Saccaro
    Chief Financial Officer, Executive Vice President
  • Sean Martin
    Senior Vice President, General Counsel
  • Jeanne Mason
    Senior Vice President - Human Resources
  • Giuseppe Accogli
    Senior Vice President, President - America
  • James Borzi
    Senior Vice President, Chief Supply Chain Officer
  • Cristiano Franzi
    Senior Vice President and President, EMEA
  • Andrew Frye
    Senior Vice President and President, APAC
  • Jacqueline Kunzler
    Senior Vice President and Chief Quality Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.